| Code | 0357A | ||||||||||
| MA number | 21/0037/82-S | ||||||||||
| Product Form: | sir 1x300 ml (fľ.skl.hn.+ dávkovač) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | G.L. Pharma GmbH, Austria | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | brown glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 01.07.1982 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| Dokument: |
DHPC_valproate 22 12 2014.pdf
|
| Dokument: |
DHPC_Valproát_19.02.2024.pdf
|
| PIL: |
PIL_Convulex sir_07.2024.pdf
|
| SPC: |
SPC_Convulex sir_07.2024.pdf
|
| Safety feature | Yes |
| Data update: | 14.05.2021 |
